Evidence map›Paper›PMID 36724409›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Ethics and Clinical Research: Improving Transparency and Informed Consent in Phase I Oncology Trials.

Paul H Frankel, Susan Groshen, Jan H Beumer, Laura Cleveland, Edward S Kim, Judith E Karp

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paul H FrankelDepartment of Computational and Quantitative Medicine, City of Hope, Duarte, CA.ORCID 0000-0003-2231-6121
Susan GroshenDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA.ORCID 0000-0001-9705-1012
Jan H BeumerCancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA.ORCID 0000-0002-8978-9401
Laura ClevelandPatient Advocate in Cancer Research, Mount Gilead, OH.
Edward S KimCity of Hope National Medical Center, Duarte, CA.
Judith E KarpJohns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.ORCID 0000-0003-4754-127X

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
The Johns Hopkins Translational Science Team for the ET-CTNUM1CA186691 · NCI · JOHNS HOPKINS UNIVERSITY · PI Jan Hendrik Beumer, Michael A Carducci · 2014 to 2026
$21.9M
NCI ET-CTN with Phase i Emphasis at UPCIUM1CA186690 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD, Farshid Dayyani · 2014 to 2026
$9.1M
PITT-CAL ETCTN PK Resource LaboratoryU24CA247643 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TIMOTHY W SYNOLD, Raman Venkataramanan · 2020 to 2026
$3.6M
NCI NIH HHS P30 CA033572NCI NIH HHS P30 CA047904NCI NIH HHS U24 CA247643NCI NIH HHS UM1 CA186690NCI NIH HHS UM1 CA186691
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Informed ConsentNeoplasmsHumansMedical Oncology

Identifiers

PMID36724409
PMCPMC10448934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.